Filing Flows › America Great Health (AAGH) › Q2 FY26 › vs Q1 FY26
America Great Health (AAGH) Q2 FY26 vs Q1 FY26 (quarter over quarter)
America Great Health's revenue fell $142K (-76%) from $188K in Q1 FY26 to $45K in Q2 FY26. The biggest changes: Anti Aging Immune Support −$117K (-81%); Targeted System Support −$17K (-55%); Herbal Insulin Support −$8K (-67%).
America Great Health, Q2 FY26: revenue $45K (-50% year over year), operating margin -440.7%, net earnings $1.1M, operating cash flow −$126K. The chart draws each line against Q1 FY26, the increases inside each band.
Every line
| Line | Q2 FY26 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Anti Aging Immune Support | $27K | $144K | −$117K | -81% |
| Targeted System Support | $14K | $31K | −$17K | -55% |
| Herbal Insulin Support | $4K | $12K | −$8K | -67% |
| Revenue | $45K | $188K | −$142K | -76% |
| Other income, net | $1.3M | −$82K | $1.4M | — |
| Costs & expenses | $1.4M | $273K | $1.1M | +397% |
| Operating costs | $244K | $191K | $53K | +28% |
| Net earnings | $1.1M | −$85K | $1.2M | — |
| Cost of revenue | $9K | $75K | −$66K | -89% |
| Operating expenses | $235K | $116K | $119K | +103% |
| Operating cash sources | $1.2M | −$126K | $1.4M | — |
| Depreciation | $4K | $4K | −$1 | 0% |
| Cash used in operations | $126K | −$44K | $171K | — |
| Working capital & other | $1.2M | −$126K | $1.4M | — |
Questions
How much did America Great Health's revenue grow quarter over quarter in Q2 FY26?
America Great Health's revenue fell $142K (-76%) from $188K in Q1 FY26 to $45K in Q2 FY26.
What drove America Great Health's revenue change in Q2 FY26?
Anti Aging Immune Support −$117K (-81%); Targeted System Support −$17K (-55%); Herbal Insulin Support −$8K (-67%).